Skip to main content
BioNTech and Pfizer Left Ad

2023 APhA Pain Institute

Advocate and Communicate: Pain Management, OUD and SUD

Thursday, March 23, 2022
8:30 AM – 5:30 PM
Convention Center, Room 125B

Registration is now closed.
How do you approach a patient who you think may be diverting?  What about a patient who is suffering from disparity, or exhibiting signs of substance use disorder?  This full day of programming related to pain management, OUD and SUD will prepare you for those difficult conversations, provide you with information related to hot topics in pain such as evidence around cannabinoid use, and arm you to advocate at multiple levels for patients in pain with or without co-occurring SUD.


(Schedule is subject to change.)

8:30AM-9:00AM – Introduction, Welcome

Emily Leppien, PharmD, BCPS, BCPP

9:00AM-10:00AM - Controversies in Conversation: Dissecting Diversion versus Mismanagement

What do you do if you are convinced a patient is diverting a prescription medication?  Do you refuse to fill the medication?  Engage the patient in conversation?  This session will review techniques to help you determine the best path forward in the controversial, uncomfortable scenario when you believe a patient may have the wrong intentions.

Thomas Franko, PharmD; Adityai Arya, FNP

10:00-10:15AM - Break

10:15AM-11:15AM - Budding Topics in Pain Management: Cannabinoids

Patients’ questions about cannabinoids have continued to grow, specifically regarding use for pain management.  You’ll be prepared to give the right answers thanks to this evidence-based discussion treating pain with various cannabinoid formulations considering their benefits and risks. Come to this session to learn about different cannabinoid formulations, the evidence to support cannabinoid use in pain, safety considerations and the legal considerations for your consultation in advocacy.

Kari Franson, PharmD

11:15AM-11:30AM - Break

11:30AM-12:30PM - Health disparities in pain, pain management, OUD/SUD

Health disparities are often discussed in the patients with diabetes or cardiovascular disease but can easily be overlooked in pain, pain management, or substance use disorder.  When it comes to pain management, racial and ethnic minorities are often given different treatment options for pain.  How can we work to acknowledge our implicit biases to give the best patient care possible?  This session aims to identify  some of the social determinants of health that may impact patients dealing with pain and pain management, as well as provide approaches for pharmacists to help address these factors to ensure optimal pain outcomes for all patients.

Laura C. Palombi, Pharm.D., MPH, MAT

12:30PM-1:30PM – LUNCH (A box lunch is included with registration.)

1:30PM-2:30PM - Tough Talks with Patients Exhibiting Signs of SUD 

What do you do when a patient starts to exhibit signs of substance use disorder?  How do you initiate a potentially difficult conversation with them?  Attend this session and learn tools and techniques that other pharmacists are using to keep these essential conversations from turning into conflicts.

Jake Nichols, PharmD, MBA

2:30PM-2:45PM - Break

2:45PM-3:45PM - Pharmacist, Advocate, Friend

Pharmacists play a critical role as advocates for patients, particularly those in pain or suffering for OUD/SUD.  This session will review strategies that experts in the field have found to help build relationships, collaborate inter-professionally, support and advocate for patients.

Anita Jacobson, PharmD

3:45PM-4:00PM - Break

4:00PM-5:15PM - Painful Conversations: Communicating with Patients in Pain Workshop

To round out the day, this exciting round table discussion will take you through a journey with complex patient scenarios.  You’ll work together to determine the best path forward, communicate efficiently and effectively as your patients advocate.

Jake Nichols, PharmD, MBA; Anita Jacobson, PharmD; Laura C. Palombi, Pharm.D., MPH, MAT

5:15PM-5:30PM – Closing remarks

Emily Leppien, PharmD, BCPS, BCPP

For a complete list of learning objectives and program information, refer to the Full Schedule.